Introduction:
The rotator cuff comprises crucial muscles that stabilize the shoulder joint, and any tear in this group can cause significant pain and restrict shoulder mobility. When conservative treatments fail to yield results, surgical intervention, particularly arthroscopic repair (a minimally invasive joint surgery), becomes the preferred approach.
However, despite advancements in techniques, retears occur in a considerable percentage of cases (ranging from 34 to 94 percent) due to poor healing between tendon and bone, resulting in the formation of fibrovascular scar tissue instead of the original fibrocartilage. This scar tissue tends to be less flexible, leading to stiffness and persistent pain. Integrating platelet-rich plasma therapy with rotator cuff repair surgery may improve outcomes. Explore further below for detailed insights.
What Is Platelet-Rich Plasma?
Platelet-rich plasma (PRP) is a concentrated form of blood cells, boasting a heightened platelet count compared to regular blood. Its rich composition includes significantly elevated levels of platelets and growth factors, typically ranging from five to ten times the normal concentration. The process of preparing PRP involves the extraction of the patient's blood, followed by centrifugation to isolate and amplify the platelets before administration through injection at the targeted site, such as the bone-tendon interface, during arthroscopic rotator cuff repair.
Within PRP, a plethora of growth factors abound, including fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-beta, and epidermal growth factor (EGF). These growth factors confer various advantages, such as expediting the healing process by delivering growth factors directly to the injured area. Moreover, PRP's safety profile is noteworthy, as it originates from the patient's blood, minimizing the risk of adverse reactions. It also possesses anti-inflammatory properties, offering potential relief from inflammation.
What Is Arthroscopic Rotator Cuff Repair?
Arthroscopic rotator cuff repair represents a surgical intervention to rectify a torn rotator cuff comprising ligaments and tendons linking the shoulder blade to the upper arm bone. This procedure utilizes an arthroscope, a miniature camera inserted into the shoulder joint via a small incision, facilitating real-time visualization of the joint's interior on a monitor. Through additional small incisions, specialized instruments are employed to mend the torn rotator cuff tendon.
Distinguished by its minimally invasive nature, arthroscopic rotator cuff repair offers several advantages. Patients typically experience reduced postoperative discomfort and improved cosmetic outcomes. Additionally, the procedure is associated with expedited healing, underscoring its appeal as a preferred treatment option.
What Is the Procedure Involved in Making Platelet-Rich Plasma?
Following collecting a blood sample from the patient it undergoes centrifugation, wherein rapid spinning separates the platelets from other blood components. Once the PRP is prepared, it can be promptly utilized by direct injection into the targeted site, such as an injured tendon, or stored for future use.
The method of administration, whether via injection or topical application, varies depending on the intended therapeutic objective. While the precise mechanism underlying PRP injections remains incompletely understood, research suggests that the elevated concentration of growth factors within platelet-rich plasma may stimulate or accelerate the healing process.
What Are the Effects of Applying Platelet-Rich Plasma During Arthroscopic Rotator Cuff Repair?
The impacts stemming from the application of platelet-rich plasma (PRP) during arthroscopic rotator cuff repair encompass a variety of effects, such as:
-
As per findings from a study, the utilization of platelet-rich plasma (PRP) resulted in a notable decrease in retear rates compared to cases where PRP was not employed. The mechanism behind PRP's efficacy lies in its ability to instigate tissue regeneration and enhance blood supply, thereby mitigating the likelihood of retears. Factors influencing retear rates include:
-
Surgeon Skill Level: Surgeon expertise plays a crucial role in retear rates; more experienced surgeons generally demonstrate lower retear rates.
-
Impact of Tear Size: Larger chronic tears repaired during surgery may heal with scar tissue, which possesses inferior biomechanical strength compared to normal tissue, potentially increasing the risk of retears.
-
Patient-Related Factors: Factors such as tissue quality, patient age, and comorbidities significantly influence retear rates.
-
-
During tendon repair, the process unfolds in three distinct stages: inflammation, proliferation characterized by the formation of new tissue, and the final maturation phase termed remodeling. Each stage demands specific growth factors for optimal healing, a need that platelet-rich plasma (PRP) effectively addresses by supplying these essential growth factors. Consequently, PRP plays a pivotal role in facilitating tendon healing by supporting each phase of the repair process with the necessary biological cues.
-
Enhanced functional outcomes were observed, marked by notable improvements in range of motion, reduction in pain levels, and increased activity participation.
-
PRP exhibits anti-inflammatory characteristics, effectively alleviating inflammation within the rotator cuff tendon and adjacent tissues, thereby reducing postoperative pain levels.
-
Certain studies propose that PRP could accelerate the recuperative journey after undergoing rotator cuff repair surgery.
-
PRP emerges as a valuable aid in wound repair, capitalizing on its ability to transport bioactive factors directly to the injury site, thus potentially augmenting the healing trajectory of the rotator cuff tendon.
-
PRP demonstrates enhanced short-term efficacy due to its ability to elevate growth factor levels around the injury site for approximately 28 days, thereby initiating the healing cascade. However, it is important to note that the complete restoration of tendon strength typically requires up to 12 months. Consequently, while PRP yields superior outcomes in the initial stages by accelerating the healing process, its long-term effects may not be as pronounced as the natural healing mechanisms of the tendon gradually take precedence, potentially diminishing PRP's impact over time.
-
PRP holds promise as a cost-effective option with the potential to mitigate the necessity for subsequent surgeries. With advancements in techniques and increasing adoption of PRP, its cost is likely to decrease, and its efficacy in averting the need for additional surgeries will improve. Such developments would yield societal benefits by curbing healthcare expenditures and enhancing patient outcomes.
Conclusion:
Applying platelet-rich plasma at the bone-tendon interface during arthroscopic rotator cuff repair yields manifold benefits. Notably, it reduces the incidence of retears while concurrently enhancing wound healing, consequently improving functional outcomes. Research findings suggest incorporating PRP into arthroscopic repairs, particularly in single-row repair procedures, can substantially enhance patients' functional recovery.
Nevertheless, it remains imperative to conduct further studies to provide additional insights into PRP's advantages. This underscores the notion that while PRP holds considerable promise in augmenting outcomes, continued research is indispensable to ascertain its efficacy and comprehensively ensure consistent, reliable results.
